Is ADMA Biologics, Inc. (ADMA) the Best Multibagger Stock to Buy According to Billionaires?

We recently published a list of 10 Best Multibagger Stocks to Buy According to Billionaires. In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other best multibagger stocks to buy according to billionaires.

US Trade tariffs have triggered heightened volatility and amplified the downdraft in the equity markets. Unlike in the previous years, where pullbacks were countered by strong buying power, investors have become increasingly cautious. The S&P 500 dropping by an incredible 6% on April 4 alone in the face of the US enacting large tariffs on global trade partners has only heightened the jitters and uncertainty in the markets.

The recent market turbulence has not spared the world’s ultra-wealthy. Following the tariff announcements, the Bloomberg Billionaires Index saw the largest two-day loss in history, wiping off almost $536 billion in worth for the world’s 500 wealthiest individuals. Similarly, prominent figures on Wall Street, including money managers and bankers, have all started raising alarms about the mounting risks of the US trade war. Legendary investor Bill Gross has also joined the fray, warning that the market rout may continue.

Amid the chaos in the equity markets, opportunities are also increasingly cropping up. The deep pullbacks have lessened the steep valuations that most stocks traded on. In the run-up to major indices rallying to record highs amid the artificial intelligence-driven rally, valuations got out of hand, skyrocketing above historical norms. Investors were subjected to premium valuations, with tech stocks most affected. Given that most stocks have given back a significant chunk of the gains accrued over the years, most are trading at multiples not seen in years. Likewise, billionaires are increasingly buying the dips that are authentic to Warren Buffett’s idea that investors should “be fearful when others are greedy, and greedy when others are fearful.” Some people think that time is at hand.

Following the lead of some of the world’s wealthiest money managers could be a smart move for investors searching for stock ideas. Fortunately, the Securities and Exchange Commission (SEC) has made it simple to see what many of them have been up to lately through mandatory disclosures. Similarly, there are stocks that have delivered significant gains over the past year, even on the overall market turning bearish. The stocks have remained resilient amid uncertainty in US interest rates, recession concerns, and trade war spat to deliver blockbuster gains.

The best multibagger stocks to buy, according to billionaires, are of companies backed by solid core business and underlying fundamentals. The robust growth of the core business in the face of the headwinds has been the primary catalyst in the stocks, delivering gains of over 200% over the past year. While it could be challenging to find reasonably priced stocks after the blockbuster gains, some are still trading below their historical norms, making them ideal value investment plays.

Our Methodology

To compile our list of multibagger stocks, we used Finviz screener to filter the top 2000 companies that have delivered at least 200% stock price return in the last twelve months. Then, we compared the list with our proprietary database of billionaire ownership as of Q4 2024 and included the top 10 names with the highest number of billionaires that own the stock. Finally, we ranked the stocks in ascending order based on the number of billionaires who hold stakes in them.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

ADMA Biologics, Inc. (NASDAQ:ADMA)

Number of Hedge Fund Holders: 37

Number of Billionaire Holders: 12

1-Year Gain as of April 22: 216.77%

ADMA Biologics, Inc. (NASDAQ:ADMA) is a biotechnology company that manufactures and commercializes speciality biologics to prevent and treat infectious diseases. The company also develops and commercializes plasma-derived products, including immune globulin therapies. It is one of the best multibagger stocks to buy, according to billionaires, going by the 216% gain over the past year. Likewise, Cantor Fitzgerald maintains an Overweight rating on the stock with a $25 price target.

Cantor Fitzgerald reiterated the buy stance while echoing the biopharmaceutical company pattern of issuing conservative revenue guidance. Last year, ADMA Biologics, Inc. (NASDAQ:ADMA) projected sales of $320 million only to deliver a 33% increase in sales to $426 million as of the end of the year. The research firm expects the company to deliver significant revenue growth in 2025 owing to expected growth in immunoglobulin therapy, ASCENIV, and the impact of high-titer plasma supply contracts.

Additionally, ADMA Biologics, Inc. (NASDAQ:ADMA) delivered impressive fourth-quarter and full-year 2024 results, underscoring success in the biopharmaceutical market. Revenue in the fourth quarter totalled $117.5 million against $113.4 million expected. On the other hand, full-year revenue increased 65% to $426.5 million as gross profit margins improved to 51.5%.

Overall, ADMA ranks 3rd on our list of best multibagger stocks to buy according to billionaires. While we acknowledge the potential of ADMA as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ADMA but that trades at less than 5 times its earnings check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.